Ligand Pharmaceuticals Inc (NASDAQ:LGND)

89.67
Delayed Data
As of May 22
 +0.44 / +0.49%
Today’s Change
41.99
Today|||52-Week Range
90.48
+68.52%
Year-to-Date

Today’s Trading

Previous close89.23
Today’s open88.91
Day’s range88.52 - 90.08
Volume211,899
Average volume (3 months)426,696
Market cap$1.8B
Dividend yield--
Data as of 3:59pm ET, 05/22/2015

Growth & Valuation

Earnings growth (last year)+31.55%
Earnings growth (this year)+32.36%
Earnings growth (next 5 years)+30.00%
Revenue growth (last year)+31.78%
P/E ratio178.7
Price/Sales16.83
Price/Book66.70

Competitors

 Today’s
change
Today’s
% change
CMRXChimerix Inc+0.65+1.54%
MDCOMedicines Co-0.39-1.42%
GLPGGalapagos NV-0.11-0.22%
MNKDMannkind Corp-0.11-2.38%
Data as of 3:59pm ET, 05/22/2015

Financials

Last reporting dateMay 11, 2015
EPS forecast (this quarter)$0.31
Annual revenue (last year)$64.5M
Annual profit (last year)$12.0M
Net profit margin18.63%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
John L. Higgins
President &
Chief Operating Officer
Matthew W. Foehr
Corporate headquarters
La Jolla, California

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers